ArticleRetina (Philadelphia, Pa.)2025
Enhancing Internal Limiting Membrane Inverted Flap Outcomes With Amniotic Solution for Chronic and Large Macular Holes.
Article in Retina (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study assesses the effectiveness of a modified inverted internal limiting membrane flap technique combined with human amniotic membrane solution for treating large, chronic, and idiopathic conditions.
methodsFourteen eyes from 14 patients underwent pars plana vitrectomy with a temporal internal limiting membrane flap technique and hAM application. Two methodologies for hAM preparation were compared: the direct injection of an hAM suspension and a refined method that used a vitrectomy probe to produce a homogeneous hAM solution. All eyes were tamponed with 20% sulfur hexafluoride.
resultsPostoperative outcomes showed significant improvements in best-corrected visual acuity and successful macular hole closure in all cases. The homogeneous hAM solution yielded superior anatomical and functional outcomes compared with the initial suspension method. It also showed better retinal layer integration without any adverse effects like displaced fragments or visual disturbances.
conclusionThis study highlights hAM solution as a promising supplement in macular hole surgery, enhancing flap stabilization and retinal regeneration. Larger studies are needed to confirm its long-term efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.